USP: Stimuli Article on Mutagenic Impurities published for Comments

Recommendation
Wednesday, 21 May 2025 10.00 - 16.00 h
How to use and prepare an MA with a CEP 2.0
Since the beginning of September 2022, the stimuli document "Mutagenic Impurities and Potentially Mutagenic Impurities in the USP-NF" has been published for comments on the website of the Pharmacopeial Forum of the USP. Comments and observations on this draft can be submitted until 30 November 2022.
This draft is divided into the following chapters and subchapters:
- Introduction
- USP Options - Alternative Scenarios under Assessment
- Proposed approaches to introduce mutagenic impurity concepts generally into the compendium
- Proposed approaches to address mutagenic impurities at the level of the monograph
- Proposed approaches to alert users to the possible presence of mutagenic impurities, either within or outside of the compendial requirements (through additional information) - Request to stakeholders
- References
To get to the stimuli document "Mutagenic Impurities and Potentially Mutagenic Impurities in the USP-NF" and to comment on it you need to first register on the Pharmacopeial Forum website.
Related GMP News
16.04.2025EDQM: Excipient Monographs and Reference Standards
09.04.2025FDA Warning Letter: Missing Ongoing Stability Program for Biotech APIs
02.04.2025WHO: Update of Guideline of Reference Standards
26.03.2025EMA: Update of "PLM Portal eAF - Release Notes"
26.03.2025PFAS Restriction in the EU: Pharma Deutschland and VDDI request Comprehensive Exemptions